Jenoptik expects ‘significant and profitable’ growth in 2021 - IDEX Health & ScienceIDEX Health & Science

    Disclaimer:

    The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Jenoptik expects ‘significant and profitable’ growth in 2021

    Article obtained from Optics.org RSS Feed.

    Company says revenue development “marked by Covid-19 pandemic” – but profitability significantly improved.

    READ MORE
    Mar, 29 2021 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.